Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study (Q33358230)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study |
scientific article |
Statements
1 reference
Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study (English)
1 reference
M A Dimopoulos
1 reference
K Zervas
1 reference
E Hatzicharissi
1 reference
A Anagnostopoulos
1 reference
M Papaioannou
1 reference
Ch Mitsouli
1 reference
P Panagiotidis
1 reference
J Korantzis
1 reference
M Tzilianos
1 reference
A Maniatis
1 reference
Greek Myeloma Study Group
1 reference
1 January 2004
1 reference
1 reference
Identifiers
1 reference